Encompass Health Corporation (EHC)
NYSE: EHC · IEX Real-Time Price · USD
82.58
+5.02 (6.47%)
At close: Mar 28, 2024, 4:00 PM
83.12
+0.54 (0.65%)
After-hours: Mar 28, 2024, 5:33 PM EDT
Encompass Health Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Encompass Health stock have an average target of 81.9, with a low estimate of 70 and a high estimate of 101. The average target predicts a decrease of -0.82% from the current stock price of 82.58.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for EHC stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 2 | 2 | 2 | 2 | 2 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Buy Maintains $95 → $101 | Buy | Maintains | $95 → $101 | +22.31% | Mar 28, 2024 |
Barclays | Barclays | Buy Initiates $95 | Buy | Initiates | $95 | +15.04% | Mar 6, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $82 → $86 | Strong Buy | Maintains | $82 → $86 | +4.14% | Feb 9, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $83 | Buy | Reiterates | $83 | +0.51% | Feb 9, 2024 |
Mizuho | Mizuho | Strong Buy Maintains $77 → $82 | Strong Buy | Maintains | $77 → $82 | -0.70% | Feb 9, 2024 |
Financial Forecast
Revenue This Year
5.31B
from 4.80B
Increased by 10.58%
Revenue Next Year
5.75B
from 5.31B
Increased by 8.36%
EPS This Year
4.01
from 3.47
Increased by 15.50%
EPS Next Year
4.43
from 4.01
Increased by 10.66%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 5.5B | 6.0B | 6.6B |
Avg | 5.3B | 5.8B | 6.3B |
Low | 5.1B | 5.5B | 6.0B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 15.5% | 13.9% | 14.9% |
Avg | 10.6% | 8.4% | 8.8% |
Low | 6.9% | 3.7% | 4.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | 4.23 | 4.85 | 5.60 |
Avg | 4.01 | 4.43 | 5.03 |
Low | 3.83 | 4.14 | 4.70 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 21.9% | 21.0% | 26.2% |
Avg | 15.5% | 10.7% | 13.4% |
Low | 10.4% | 3.2% | 6.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.